Pelvic Organ ProlapseNCT07786337
How Low Can You Go
A study testing Standard insufflation and Low insufflation in people with Pelvic Organ Prolapse, run by University of Calgary.
Trial summary
This is a randomized controlled trial to determine if lower intraabdominal operating pressure reduces post-operative pain in patients scheduled to undergo laparoscopic uterosacral suspension surgery of the uterus or vaginal vault. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Pelvic Organ Prolapse
- What is being tested?
- Standard insufflation and Low insufflation
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 164 participants
- Where
- No sites listed yet
- Study dates
- Sep 2026to Feb 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- ≥18 years of age
- planned laparoscopic uterosacral suspension surgery of the uterus or vaginal vault
- patients with planned concomitant prolapse, hysterectomy, or anti-incontinence surgeries will be included
Who cannot join
- non-urogynecologic procedures, or conversion to open abdominal surgery will be excluded as additional or alternative sites of pain may contribute to possible confounding for the primary outcome of postoperative pain
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
Louise Gofton contact
About this study
Official title: How Low Can You Go: a Randomized Controlled Trial of Normal Versus Low Intraabdominal Pressure During Laparoscopic Uterosacral Suspension Surgery
This is a randomized controlled trial to determine if lower intraabdominal operating pressure reduces post-operative pain in patients scheduled to undergo laparoscopic uterosacral suspension surgery of the uterus or vaginal vault.
Read the detailed description
The primary objective of this research proposal is to answer the question: in patients scheduled to undergo laparoscopic uterosacral suspension surgery of the uterus or vaginal vault, does lower intraabdominal operating pressure reduce post-operative pain, measured using a standardized visual analogue scale?
Secondary outcomes include frequency of opioid and non-opioid analgesic prescriptions at time of discharge, rescue opioid analgesics in the day-surgery recovery unit, rate of unanticipated admission to hospital. Surgical safety outcomes will also be assessed including surgeon perception of operative field visibility, rate of surgeon requests to increase intraabdominal pressure, rate of conversion to open surgery, incidence of surgical complications (up to 30d post-operatively).
3.0 METHODS \& STATISTICAL ANALYSIS This study will be a double-blinded randomized controlled trial patients ≥18 years of age scheduled for laparoscopic uterosacral suspension surgery of either the uterus or vaginal vault at the Foothills Medical Centre, an academic tertiary hospital. Patients scheduled to receive concomitant prolapse, hysterectomy, or anti-incontinence surgeries will be included. Patients scheduled to receive concomitant non-urogynecologic surgery or those converted to an open, abdominal surgical approach will be excluded. For participants randomized to the lower IAP group, after entry into the abdominal-pelvic cavity, pneumoperitoneum pressure will be set and maintained at 10mmHg throughout the surgery. For those randomized to the normal IAP group, after entry into the abdominal-pelvic cavity, pneumoperitoneum pressure will be set and maintained at 15mmHg.
Data collected - including but not limited to:
- Preoperative data:
- Baseline demographics: age, BMI, past medical history
- Intraoperative Data:
- Duration of surgery, estimated blood loss, surgical complications
- Incidence of surgeon request for either: an increase in Trendelenburg positioning or increase in intraabdominal pressure settings
- Postoperative Data:
- Visual analogue pain scores (0-100mm) at 3 and 24 hours postoperatively
- Incidence of postoperative non-opioid and opioid prescriptions provided
- Incidence of unplanned hospital admission
The baseline characteristics of the primary cohort will be presented. Categorical data will be reported as counts and percentages and continuous data as means with standard deviations.
Continuous variables will be analyzed using a Student t-test for normally distributed data and Wilcoxon's rank sum test for nonparametric data. Frequencies and percentages will be calculated for categorical variables and compared using the Chi-squared or Fisher's exact test as appropriate. Statistical significance will be defined as p<0.05.
Prior studies determined the minimum clinically significant difference in visual analogue pain scales scores to be 10mm, regardless of severity of pain. On the basis of this, a sample of 64 patients per group will be sought to achieve 80% power to detect an effect size of 0.5 (i.e. assuming a standard deviation of two points on the pain scale) using a two-group t-test with a two-sided significance level of 0.05. Accounting for a drop-out rate of 20%, a final sample size to 164 patients will be required.
- Conditions
- Pelvic Organ Prolapse
- Being tested
- Standard insufflation, Low insufflation
- Keywords
- pelvic organ prolapse, laparoscopy, insufflation
- Medical subject headings
- Pelvic Organ Prolapse
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard insufflationProcedure or surgery
standard insufflation pressure of 15 mm Hg
Low insufflationProcedure or surgery
10 mm Hg of insufflation pressure
| Study group | Role | What they receive |
|---|---|---|
| Standard insufflation | Active comparator | 15 mmHg Receives: Procedure: Standard insufflation |
| Low Insufflation | Experimental | 10 mm Hg Receives: Procedure: Low insufflation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative Pain Visual Analog Scale
Visual analog scale minimum 0 maximum 10 0 means no pain 10 means worst possible pain
Measured: 3 hours and 24 hours postop
Secondary outcomes (2)
Post-operative analgesia
total dose of morphine milligram equivalents MME used during first days after surgery.
Measured: 0 - 3 days postoperative
Surgeon visibility
surgeon rating of intraoperative visibility on a Likert scale of 0 - 10. 0 means no visibility. 10 = optimum visibility.
Measured: immediately after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Aug 2026
- Study startSep 2026 (estimated)
- Primary completionSep 2027 (estimated)
- Study completionFeb 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pelvic Organ ProlapseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 164 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Calgary
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shunaha Kim-Fine, University of Calgary
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07786337
- Sponsor's protocol ID
- REB25-0779
- Status last verified
- Aug 2026
- First submitted
- 15 Aug 2026
- Last updated
- 26 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: against local IRB
Study at a glance
From the registry record, last updated by the sponsor on 26 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- How Low Can You Go: a Randomized Controlled Trial of Normal Versus Low Intraabdominal Pressure During Laparoscopic Uterosacral Suspension Surgery
- ClinicalTrials.gov ID
- NCT07786337
- Acronym / sponsor ID
- REB25-0779
- Conditions
- Pelvic Organ Prolapse
- Keywords
- pelvic organ prolapse, laparoscopy, insufflation
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 164 participants (estimated)
- Lead sponsor
- University of CalgaryUniversity, hospital or other
- Study start
- Sep 2026 (estimated)
- Primary completion
- Sep 2027 (estimated)
- Study completion
- Feb 2028 (estimated)
- First posted
- 26 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a randomized controlled trial to determine if lower intraabdominal operating pressure reduces post-operative pain in patients scheduled to undergo laparoscopic uterosacral suspension surgery of the uterus or vaginal vault.
Detailed description
The primary objective of this research proposal is to answer the question: in patients scheduled to undergo laparoscopic uterosacral suspension surgery of the uterus or vaginal vault, does lower intraabdominal operating pressure reduce post-operative pain, measured using a standardized visual analogue scale?
Secondary outcomes include frequency of opioid and non-opioid analgesic prescriptions at time of discharge, rescue opioid analgesics in the day-surgery recovery unit, rate of unanticipated admission to hospital. Surgical safety outcomes will also be assessed including surgeon perception of operative field visibility, rate of surgeon requests to increase intraabdominal pressure, rate of conversion to open surgery, incidence of surgical complications (up to 30d post-operatively).
3.0 METHODS \& STATISTICAL ANALYSIS This study will be a double-blinded randomized controlled trial patients ≥18 years of age scheduled for laparoscopic uterosacral suspension surgery of either the uterus or vaginal vault at the Foothills Medical Centre, an academic tertiary hospital. Patients scheduled to receive concomitant prolapse, hysterectomy, or anti-incontinence surgeries will be included. Patients scheduled to receive concomitant non-urogynecologic surgery or those converted to an open, abdominal surgical approach will be excluded. For participants randomized to the lower IAP group, after entry into the abdominal-pelvic cavity, pneumoperitoneum pressure will be set and maintained at 10mmHg throughout the surgery. For those randomized to the normal IAP group, after entry into the abdominal-pelvic cavity, pneumoperitoneum pressure will be set and maintained at 15mmHg.
Data collected - including but not limited to:
- Preoperative data:
- Baseline demographics: age, BMI, past medical history
- Intraoperative Data:
- Duration of surgery, estimated blood loss, surgical complications
- Incidence of surgeon request for either: an increase in Trendelenburg positioning or increase in intraabdominal pressure settings
- Postoperative Data:
- Visual analogue pain scores (0-100mm) at 3 and 24 hours postoperatively
- Incidence of postoperative non-opioid and opioid prescriptions provided
- Incidence of unplanned hospital admission
The baseline characteristics of the primary cohort will be presented. Categorical data will be reported as counts and percentages and continuous data as means with standard deviations.
Continuous variables will be analyzed using a Student t-test for normally distributed data and Wilcoxon's rank sum test for nonparametric data. Frequencies and percentages will be calculated for categorical variables and compared using the Chi-squared or Fisher's exact test as appropriate. Statistical significance will be defined as p<0.05.
Prior studies determined the minimum clinically significant difference in visual analogue pain scales scores to be 10mm, regardless of severity of pain. On the basis of this, a sample of 64 patients per group will be sought to achieve 80% power to detect an effect size of 0.5 (i.e. assuming a standard deviation of two points on the pain scale) using a two-group t-test with a two-sided significance level of 0.05. Accounting for a drop-out rate of 20%, a final sample size to 164 patients will be required.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Standard insufflation | Active comparator | Procedure: Standard insufflation15 mmHg |
| Low Insufflation | Experimental | Procedure: Low insufflation10 mm Hg |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- ≥18 years of age
- planned laparoscopic uterosacral suspension surgery of the uterus or vaginal vault
- patients with planned concomitant prolapse, hysterectomy, or anti-incontinence surgeries will be included
Key exclusion criteria (1 listed)
- non-urogynecologic procedures, or conversion to open abdominal surgery will be excluded as additional or alternative sites of pain may contribute to possible confounding for the primary outcome of postoperative pain
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard insufflationstandard insufflation pressure of 15 mm Hg | Procedure or surgery | Standard insufflation |
| Low insufflation10 mm Hg of insufflation pressure | Procedure or surgery | Low Insufflation |
Primary outcome
Postoperative Pain Visual Analog Scale
Time frame: 3 hours and 24 hours postop
Visual analog scale minimum 0 maximum 10 0 means no pain 10 means worst possible pain
2 secondary outcomes
Post-operative analgesia
Time frame: 0 - 3 days postoperative
Surgeon visibility
Time frame: immediately after surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Aug 2026.
- Individual participant dataSharing planned: No. against local IRB
Related trials for Pelvic Organ Prolapse
Recruiting
Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious)
Pelvic Organ Prolapse (POP), Synthetic Mesh
Active, not recruitingObservational study
i-Stitch for Bilateral Sacrospinous Ligament Fixation (SSLF)
Pelvic Organ Prolapse, Genital Prolapse
Recruiting
Pelvic Floor Muscle Training During Pregnancy
Urinary Incontinence, Anal Incontinence
Not yet recruiting
Perineal Protection Device for Reducing Perineal Trauma During Vaginal Delivery in First-time Mothers: a Multicenter Randomized Controlled Trial
Pelvic Floor Dysfunction, Perineal Laceration
Not yet recruitingPhase 4
Suzetrigine Following Urogynecologic Surgery: Investigation of Postoperative Pain Management
Pelvic Organ Prolapse (POP), Postoperative Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Louise Gofton contact
Questions about this trial
What is this clinical trial studying?
A study testing Standard insufflation and Low insufflation in people with Pelvic Organ Prolapse, run by University of Calgary.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 26 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Shunaha Kim-Fine, MD MS (403-944-1438, skimfine@ucalgary.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative Pain Visual Analog Scale (time frame: 3 hours and 24 hours postop). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2026.